A real‐life pilot study of the clinical application of pharmacogenomics testing on saliva in epilepsy

A real‐life pilot study of the clinical application of pharmacogenomics testing on saliva in epilepsy

Abstract Response to antiseizure medications (ASMs) can be influenced by several gene polymorphisms, causing either lower efficacy or higher occurrence of adverse drug reactions (ADRs). We investigated the clinical utility of salivary pharmacogenomic testing on epilepsy patients. A commercialized ph...

Full description

Bibliographic Details
Main Authors: Antonella Riva, Roberta Roberti, Gianluca D'Onofrio, Maria Stella Vari, Elisabetta Amadori, Valentina De Giorgis, Caterina Cerminara, Nicola Specchio, Nicola Pietrafusa, Mario Tombini, Giovanni Assenza, Silvia Cappanera, Carla Marini, Paolo Rasmini, Pierangelo Veggiotti, Federico Zara, Emilio Russo, Pasquale Striano
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Epilepsia Open
Subjects:
antiseizure medications
epilepsy
pharmacogenomics
precision medicine
Online Access:https://doi.org/10.1002/epi4.12717

Internet

https://doi.org/10.1002/epi4.12717

Similar Items